SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)
Status:
Terminated
Trial end date:
2019-09-20
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the tolerability, efficacy and safety of a new lithium
sulphate prolonged release formulation (Lithiofor®) in patients affected by Bipolar Disorder
poor tolerant to lithium immediate-release treatment in terms of lithium-induced tremor when
switched from therapy with a lithium carbonate immediate release formulation (Carbolithium®)
to a new lithium sulphate prolonged release formulation (Lithiofor®).